Skip to main content
SpringerLink
Log in

Methodische Anforderungen an eine anwendungsorientierte klinische Forschung

  • Conference paper
Book cover Zeitfragen der Medizin

  • 36 Accesses

Zusammenfassung

Ziel einer anwendungsorientierten klinischen Forschung muß es sein, die Möglichkeiten zur Vorbeugung, zur Erkennung und vor allem zur Behandlung von Krankheiten zu verbessern. Der vorliegende Beitrag beschäftigt sich mit der klinisch-therapeutischen Forschung, also der Entwicklung wirksamer und sicherer Behandlungsmethoden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. Abel U, Windeler J (1997) Erkenntnistheoretische Aspekte klinischer Studien Teil 3. Fallstudie ASI. Fehlurteile und unfundierte Schlüsse in klinischen Therapieprüfungen. Internistische Praxis 37: 619–629

    Google Scholar 

  2. Andersen B (1990) Methodological errors in medical research. An incomplete catalogue. Oxford Blackwell Scientific Publications

    Google Scholar 

  3. Berges RR, Windeier J, Trampisch HJ, Senge TH and the β-Sitosterol Study Group (1995) Randomized, placebo-controlled, double-blind clinical trial of β-Sitosterol in patients with benign prostatic hyperplasia. Lancet 345: 1529–1532

    Google Scholar 

  4. CAPS Investigators (1988) Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Amer J Cardiol 61: 501–509

    Article  Google Scholar 

  5. Committee of principal investigators (1978) A cooperative trial in the primary prevention of ischaemic heart disease using dofibrate. British Heart Journal 40: 1069–1118

    Article  Google Scholar 

  6. Cuzick J et al (1987) Overview of randomized trials of post-operative adjuvant radiotherapy in breast cancer. Cancer Treatment Reports 71: 15–29

    PubMed  CAS  Google Scholar 

  7. Del Carpio et al (1989) Efficacy and safety of loratadine (10 mg once daily), terfena-dine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology 84: 741–746

    Article  Google Scholar 

  8. Donner-Banzhoff N (1994) Die Aschenputtel-Methode. Z Allg Med 70: 1–2

    Google Scholar 

  9. Echt DS et al (1991) Mortality and morbidity in patients receiving Encainide, Flecainide or Plazebo. The cardiac arrhythmia suppression trial. New England Journal of Medicine 324: 781–788

    CAS  Google Scholar 

  10. Evemy KL, Pentecost BL (1978) Intravenous and oral practolol in the acute stages of myocardial infarction. Eur J Cardiol 7: 391–398

    PubMed  CAS  Google Scholar 

  11. Geelhoed GC, Macdonald WBG (1995) Oral and Inhaled Steroids in Croup. A Randomized, Plazebo-Controlled Trial. Pediatric Pulmonology 20: 355–361

    CAS  Google Scholar 

  12. Hampton JR, van Velduisen DJ, Kleber FX et al (1997) Randomized Study of Effect of Ibopamine on Survival in Patients with Advanced Severe Heart Failure. Lancet 349: 971–977

    Article  PubMed  CAS  Google Scholar 

  13. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceutics for Human Use, CPMP/ICH/135/95, ICH-EWG-E6 Good Clinical Practice: Consolidated Guideline

    Google Scholar 

  14. ISIS-1 (1986) Randomized trial of intravenous atenolol among 16.027 cases of suspected myocardial infarction. Lancet 2: 57–66

    Google Scholar 

  15. Lees AJ and the Parkinson’s disease research group of the United Kingdom (1995) Comparison of therapeutic effects and mortality data of Levodopa and Levodopa combined with Selegiline in patients with early, mild Parkinson’s disease. British Medical Journal Dec 16; 311: 1602–1607

    Google Scholar 

  16. Loftus BG, Price JF (1987) Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma. Journal of Allergy and Clinical Immunology 79: 350–355

    Article  PubMed  CAS  Google Scholar 

  17. Maschio G et al (1996) Effect of the angiotensin-converting-enzyme inhibitor Benazepril on the progression of chronic renal insufficiency. New England Journal of Medicine 334: 939–945

    Article  PubMed  CAS  Google Scholar 

  18. Non small cell lung cancer collaborative group (1995) Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 250 randomized clinical trials. British Medical Journal 311: 899–909

    Article  Google Scholar 

  19. Packer M et al (1991) Effect of oral Milrinone on mortality in severe chronic heart failure. New England Journal of Medicine 325: 1468–1508

    Article  PubMed  CAS  Google Scholar 

  20. Pocock SJ (1977) Group sequential methods in the design and analysis of clinical trials. Biometrika 64: 191–199

    Article  Google Scholar 

  21. Sacks H et al (1982) Randomized versus historical controls for clinical trials. The American Journal of Medicine 72: 233–240

    Article  PubMed  CAS  Google Scholar 

  22. Skassa-Brociek W et al (1988) Double-blind placebo controlled study of loratadine, me-quitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology 81: 725–730

    Article  PubMed  CAS  Google Scholar 

  23. Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W (1996) A Plazebo-Controlled, Randomized Clinical Trial Comparing Sertraline and Imipramine for the Treatment of Dysthymia. Archives of General Psychiatry, Vol. 53, Sep pp. 777–784

    Article  PubMed  CAS  Google Scholar 

  24. The EC/IC Bypass Study Group (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischaemic stroke. New England Journal of Medicine 313: 1191–1200

    Article  Google Scholar 

  25. The Prova-Study Group: Prophylaxis of first hemorrhage from esophargial varizes bei sclerotherapy, Propranolole or both in cyrrhotic patients: a randomized multicenter trial. Hepatology 1991; 14: 1016–1024

    Article  Google Scholar 

  26. Van de Ven LLM, Mouthaan WJ, Hoes MJAJM (1995) Treatment of the hyperventilation syndrome with bisoprolol: a placebo-controlled clinical trials. Journal of Psychosomatic Research Vol. 39 Nr. 8, S 1007–1013

    Article  Google Scholar 

  27. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil ]DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP, for the SWORD investigators (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The Lancet, Vol. 348, July 6, pp. 7–12

    Article  CAS  Google Scholar 

  28. Wiesenfeld M, O’Connell MJ, Wieand HS, Gonchoroff NJ, Donohue JH, Fitzgibbons RJ jun, Krook JE, Mailliard JA, Gerstner JB, Pazdur R (1995) „Controlled clinical trial of interferon-gamma as post-operative surgical adjuvant therapy for colon cancer.“ Journal of Clinical Oncology, 1995, Sep; 13 (9): 2324–2329

    Google Scholar 

  29. Wolf M, Hans K, Becker H, Hassler R, von Bultzingslowen F, Goerg R, Klaasen HA, Dannhauser J, Holle R, Pfab R et al (1994) Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. Semin Oncol 121(3 Suppl 4): 42–7

    Google Scholar 

  30. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) α-Blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases Vol. XXVII No. 5 (March/April) 1985: pp. 335–371

    Article  Google Scholar 

Download references

Authors
  1. Helmut Schäfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ferdinand-Sauerbruch-Klinikum Klinikum Wuppertal GmbH Akademisches Lehrkrankenhaus der Heinrich-Heine-Universität Düsseldorf, Klinikum der Universität Witten/Herdecke, Arrenberger Straße 20, D-42117, Wuppertal, Deutschland

    Johannes Köbberling

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schäfer, H. (1998). Methodische Anforderungen an eine anwendungsorientierte klinische Forschung. In: Köbberling, J. (eds) Zeitfragen der Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-51117-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-51117-2_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63582-6

  • Online ISBN: 978-3-642-51117-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation